Experimental Alzheimer's drug repairs DNA damage in mice, study finds
Experimental Alzheimer's drug repairs DNA damage in mice, study finds
Experimental Alzheimer's drug repairs DNA damage in mice, study finds
Key points
اہم نکات
मुख्य बातें
- Researchers at King's College London have found that an experimental drug called KCL-286 repaired damaged DNA and reduced brain inflammation in a mouse model of Alzheimer's disease.
- The drug was originally developed for spinal cord injury and has already passed Phase 1 human safety trials, which could speed up further testing.
- Its effectiveness against Alzheimer's in people has not yet been established, and more clinical trials are needed.
- Researchers at King's College London have found that an experimental drug called KCL-286 repaired damaged DNA and reduced brain inflammation in a mouse model of Alzheimer's disease.
- The drug was originally developed for spinal cord injury and has already passed Phase 1 human safety trials, which could speed up further testing.
- Its effectiveness against Alzheimer's in people has not yet been established, and more clinical trials are needed.
- Researchers at King's College London have found that an experimental drug called KCL-286 repaired damaged DNA and reduced brain inflammation in a mouse model of Alzheimer's disease.
- The drug was originally developed for spinal cord injury and has already passed Phase 1 human safety trials, which could speed up further testing.
- Its effectiveness against Alzheimer's in people has not yet been established, and more clinical trials are needed.
Researchers at King's College London have found that an experimental drug called KCL-286 repaired damaged DNA and reduced brain inflammation in a mouse model of Alzheimer's disease. The drug was originally developed for spinal cord injury and has already passed Phase 1 human safety trials, which could speed up further testing. Its effectiveness against Alzheimer's in people has not yet been established, and more clinical trials are needed.
Researchers at King's College London have found that an experimental drug called KCL-286 repaired damaged DNA and reduced brain inflammation in a mouse model of Alzheimer's disease. The drug was originally developed for spinal cord injury and has already passed Phase 1 human safety trials, which could speed up further testing. Its effectiveness against Alzheimer's in people has not yet been established, and more clinical trials are needed.
Researchers at King's College London have found that an experimental drug called KCL-286 repaired damaged DNA and reduced brain inflammation in a mouse model of Alzheimer's disease. The drug was originally developed for spinal cord injury and has already passed Phase 1 human safety trials, which could speed up further testing. Its effectiveness against Alzheimer's in people has not yet been established, and more clinical trials are needed.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।